"Direct-To-Consumer" Genetic Testing - Market Expected to Triple in Five Years

Patient is king when it comes to certain types of testing, especially genetic tests. A new report from Kalorama Information finds fast growth in direct-to-consumer testing.

  • by Bruce Carlson
  • February 21 2018


Four Things to Know About The Monoclonal Antibodies – “mAbs” Market

From the best region for sales to the best type of Monoclonal Antibodies, this article provides 4 points about the market, as developed in our report. This according to our report, according to Kalorama Information's new report What's Trending in Monoclonal Antibodies.


6 Steps for Determining Market Size in the Healthcare Sector

6 Steps for Determining Market Size in the Healthcare Sector

The computation of market sizes in healthcare is tricky. In this article, we provide 6 tips to computing market sizes for healthcare products, instruments and reagents. While not used in every Kalorama report, these techniques are used in most of them.

  • by Bruce Carlson
  • February 6 2018
  • IVD


5 IVD Market Trends to Watch in 2018

5 IVD Market Trends to Watch in 2018

From syndromic testing to the microbiome, watch these five in vitro diagnostic market trends as they develop this year.


Severe Flu Season Provides an Opportunity for Molecular POC

Severe Flu Season Provides an Opportunity for Molecular POC

Molecular POC systems get their chance to prove themselves in a severe flu season, says analyst Rob Camp: "The gold standard for diagnostics is real-time PCR, but...PCR is time-consuming, because of the preparation and the complexity of its mechanism...So for a few years now, big biotech firms have been working on better solutions, employing nucleic acid amplification techniques that make PCR so accurate and engineering them into relatively tiny and simple packages"


Big Events in Biosimilars

Big Events in Biosimilars

Two big events in the news involving biosimilars: a large deal and an important approval


Biotechnology Fights HAI

Biotechnology Fights HAI

illnesses that are most commonly acquired in hospital settings are a formidable foe, but biotech is ready, as this article details.

  • by Bruce Carlson
  • January 8 2018
  • ACA


$185 Billion-Dollar U.S. Medical Device Industry Reckons With Return of Tax

$185 Billion-Dollar U.S. Medical Device Industry Reckons With Return of Tax

Surprise! The new year arrived with the return of a new tax for device makers who manufacture and sell into the U.S., as well as those who import into the largest medical device market. We examine the effects, and some good news, in this article.


IVD Responds to Sepsis with Rapid Testing Solutions

IVD Responds to Sepsis with Rapid Testing Solutions

Sepsis is a scourge for the healthcare system in the U.S. and abroad, but is also an area that has received significant attention from major IVD makers. Now rapid solutions are entering the mix.


CRISPR: As Powerful a Tool in Finding Disease As It Is in Treating It

CRISPR: As Powerful a Tool in Finding Disease As It Is in Treating It

The most obvious applications for CRISPR lie in gene therapy, while consideration is being made as well into other avenues of development, such as pharmaceuticals and agriculture, and there is incredible potential in etiological research by way of easily creating new genetic animal models. But a variant of the technique, called SHERLOCK, could become a vital and versatile tool in diagnostics and outbreak management. SHERLOCK, or Specific High-sensitivity Enzymatic Reporter unLOCKing, is a CRISPR-based system in that it uses a gRNA and an enzyme to find and cut DNA, respectively